SUPPLY CHAIN CHALLENGES LEAD TO REDUCED TARGET FOR VACCINE DOSES IN 2020: Pfizer

Highlights

• While it had stated that it would be producing about 100 million doses of vaccine this year, U.S. pharmaceutical giant recently said that it anticipates producing 50 million doses

• The vaccine developed by Pfizer along with Germany’s BioNTech is dependant on a two dose regimen, which means 50 million doses will be used to vaccinate 25 million people

• Along with the United States....